Insmed Financials

INSM Stock  USD 28.06  0.34  1.23%   
Based on the measurements of operating efficiency obtained from Insmed's historical financial statements, Insmed Inc may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, Insmed's Total Liabilities is very stable as compared to the past year. As of the 2nd of March 2024, Current Liabilities is likely to grow to about 243.4 M, while Accumulated Other Comprehensive Income is likely to drop (764.6 K). Key indicators impacting Insmed's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Return on Equity3.943.649
Significantly Up
Very volatile
Debt to Equity Ratio(5.14)(5.006)
Fairly Down
Pretty Stable
Current Ratio5.174.118
Significantly Up
Slightly volatile
The financial analysis of Insmed is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Insmed includes many different criteria found on its balance sheet. For example, investors should never minimize Insmed's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Insmed's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Insmed.

Cash and Equivalents

511.15 Million

With this module, you can analyze Insmed financials for your investing period. You should be able to track the changes in Insmed individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Insmed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Insmed's financial statements are interrelated, with each one affecting the others. For example, an increase in Insmed's assets may result in an increase in income on the income statement.
Evaluating Insmed's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Insmed's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Insmed's relative financial performance

Chance Of Distress

Over 60

 
100  
 
Zero
Above Average
Insmed Inc has more than 60 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Insmed stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Insmed's odds of distress score SHOULD NOT be confused with the real chance of Insmed Inc filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Insmed is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Insmed's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Insmed's official financial statements usually reflect Insmed's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Insmed Inc. For example, before you start analyzing numbers published by Insmed accountants, it's critical to develop an understanding of what Insmed's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Insmed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Insmed's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Insmed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Insmed Inc. Please utilize our Beneish M Score to check the likelihood of Insmed's management manipulating its earnings.

Insmed Company Summary

Insmed competes with Sphere Entertainment, Software Acquisition, NeogamesSA, Boston Omaha, and Cimpress. Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey. Insmed operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 613 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CIK Number0001104506
ISINUS4576693075
CUSIP457669109
RegionNorth America
LocationNew Jersey; U.S.A
Business Address700 US Highway
SectorBiotechnology
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.insmed.com
Phone908 977 9900
CurrencyUSD - US Dollar
You should never invest in Insmed without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Insmed Stock, because this is throwing your money away. Analyzing the key information contained in Insmed's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Insmed Key Financial Ratios

Generally speaking, Insmed's financial ratios allow both analysts and investors to convert raw data from Insmed's financial statements into concise, actionable information that can be used to evaluate the performance of Insmed over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Insmed Inc reports annually and quarterly.

Insmed Key Balance Sheet Accounts

201920202021202220232024 (projected)
Inventories28.3M49.6M67.0M69.9M62.9M51.8M
Receivables19.2M16.6M24.4M29.7M26.7M28.9M
Accounts Payable13.2M42.9M35.8M50.5M45.4M49.0M
Total Assets742.3M796.2M1.2B1.7B1.3B1.1B
Current Assets555.2M622.9M837.0M1.3B929.1M797.6M
Assets Non Current187.1M173.3M406.5M383.1M400.8M432.4M
Cash and Equivalents487.4M532.8M716.8M1.1B482.4M511.2M
Total Debt397.0M404.8M612.3M1.3B1.4B1.5B
Debt Non Current384.8M392.3M602.1M1.3B1.3B1.5B
Inventory28.3M49.6M67.0M69.9M83.2M73.3M
Total Liabilities480.6M520.3M833.0M1.6B1.7B1.8B
Current Liabilities85.2M118.8M135.2M190.2M225.6M243.4M

Insmed Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Insmed's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Direct Expenses24.2M39.9M44.2M55.1M49.6M40.1M
Consolidated Income(254.3M)(294.1M)(434.7M)(481.5M)(749.6M)(769.3M)
Cost of Revenue24.2M39.9M44.2M55.1M65.6M56.8M
Gross Profit112.3M124.5M144.3M190.2M239.6M194.8M
Interest Expense27.7M29.6M40.5M26.4M81.7M88.1M
Net Income(254.3M)(294.1M)(434.7M)(481.5M)(749.6M)(769.3M)
Operating Expenses347.5M389.8M519.4M647.6M949.3M1.0B
Operating Income(235.2M)(265.2M)(375.1M)(457.3M)(709.6M)(728.3M)
Revenues136.5M164.4M188.5M245.4M305.2M248.4M
Income Tax Expense777K1.4M(1.8M)1.4M2.6M2.8M

Insmed Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Insmed Inc. It measures of how well Insmed is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Insmed brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Insmed had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Insmed has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Capital Expenditure(42.3M)(6.2M)(7.3M)(9.9M)(13.3M)(14.3M)
Depreciation Amortization and Accretion19.9M20.1M26.8M22.3M19.8M16.9M
Net Cash Flow or Change in Cash and Cash Equivalents(7.6M)45.3M184.0M357.3M(591.7M)(607.2M)
Issuance Purchase of Equity Shares280.8M271.9M291.9M311.7M170.9M201.8M
Net Cash Flow from Financing285.3M271.0M612.5M793.3M168.4M264.5M
Net Cash Flow from Investing(42.3M)(6.8M)(64.3M)(34.6M)(223.6M)(229.5M)
Net Cash Flow from Operations(250.6M)(219.3M)(363.3M)(400.4M)(536.2M)(550.4M)
Effect of Exchange Rate Changes on Cash(4K)494K(933K)(996K)(250K)(269.7K)
Share Based Compensation27.0M36.2M46.0M57.7M74.8M80.7M

Insmed Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Insmed's current stock value. Our valuation model uses many indicators to compare Insmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Insmed competition to find correlations between indicators driving Insmed's intrinsic value. More Info.
Insmed Inc is currently regarded as number one stock in current asset category among related companies. It is currently regarded as number one stock in cash and equivalents category among related companies creating about  19.71  of Cash And Equivalents per Current Asset. At this time, Insmed's Cash and Equivalents is very stable as compared to the past year.. Comparative valuation analysis is a catch-all model that can be used if you cannot value Insmed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Insmed's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Insmed's earnings, one of the primary drivers of an investment's value.

Insmed Inc Systematic Risk

Insmed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Insmed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was six with a total number of output elements of fifty-five. The Beta measures systematic risk based on how returns on Insmed Inc correlated with the market. If Beta is less than 0 Insmed generally moves in the opposite direction as compared to the market. If Insmed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Insmed Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Insmed is generally in the same direction as the market. If Beta > 1 Insmed moves generally in the same direction as, but more than the movement of the benchmark.
.

About Insmed Financials

What exactly are Insmed Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Insmed's income statement, its balance sheet, and the statement of cash flows. Potential Insmed investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Insmed investors may use each financial statement separately, they are all related. The changes in Insmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Insmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Insmed Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Insmed is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Insmed has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Insmed's financials are consistent with your investment objective using the following steps:
  • Review Insmed's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Insmed's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Insmed's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Insmed's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Insmed March 2, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Insmed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Insmed Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Insmed Inc based on widely used predictive technical indicators. In general, we focus on analyzing Insmed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Insmed's daily price indicators and compare them against related drivers.
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stocks Directory
Find actively traded stocks across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CEOs Directory
Screen CEOs from public companies around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.34)
Revenue Per Share
2.173
Quarterly Revenue Growth
0.411
Return On Assets
(0.28)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.